Fante already fronts the company's commercial operations in North America. He will now also take on Central and South American responsibilities.
"Rich is a strong leader who will enable our company to successfully navigate the challenges facing our industry while delivering innovation and value to our customers, patients and shareholders," said Tony Zook, executive VP, global commercial operations.
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...
The US Government has dropped charges against senior Lilly scientists accused of sharing company secrets.
Plus the latest drug industry hirings, firings and awards in this week's column.
The Association of the British Pharmaceutical and novel drugmakers feature in this week's People on the Move...